Certified by Founder Lodge
Flagship Pioneering
United States - Cambridge, MA
INVESTOR
2 Disclosed Funding Rounds $350,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 23 ,2023 | Unknown | $50,000,000 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Harbinger Health |
September, 29 ,2023 | Series B | $140,000,000 |
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
 Ring Therapeutics |
March, 10 ,2023 | Series C | $86,500,000 |
 Ampersand Biomedicines |
March, 26 ,2025 | Series B | $65,000,000 |
 Metaphore Biotechnologies |
May, 18 ,2023 | Unknown | $50,000,000 |
 Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
 Indigo |
September, 19 ,2023 | Unknown | $250,000,000 |
| Harbinger Health |
September, 29 ,2023 | Series B | $140,000,000 |
| Ampersand Biomedicines |
March, 26 ,2025 | Series B | $65,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
BuildVision | $10,000,000 | (Mar 28, 2025)
Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
